Teleflex said that the sale proceeds are approximately $94m and actuation will be reflected as a discontinued operation in Teleflex’s future consolidated financial statements.
On 29 November 2010, Teleflex has entered into a definite agreement with TransDigm Group for approximately $94m.
Teleflex is a global provider of medical technology products that enable healthcare providers to improve patient outcomes, reduce infections and support patient and provider safety.
